ConductScience.org, home

Paper38937372

Stability of Protein Pharmaceuticals: Recent Advances.

Manning MC and 10 others. Pharm Res, 2024. Cited by 29 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Stability of Protein Pharmaceuticals: Recent Advances. Papers, record 38937372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38937372

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Stability of Protein Pharmaceuticals: Recent Advances.
PubMed
Journal
Pharm Res
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
6.04, provisional
iCite
Revised in PubMed
2026-11-01
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Manning MCMark Cornell
2Holcomb RERyan E
3Payne RWRobert W
4Stillahn JMJoshua M
5Connolly BDBrian D
6Katayama DSDerrick S
7Liu HHongcheng
8Matsuura JEJames E
9Murphy BMBrian M
10Henry CSCharles S
11Crommelin DJADaan J A

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Protein StabilityMajor topic
ProteinsMajor topic
Drug StabilityMajor topic
Humans
Excipients
Drug Compounding
Chemistry, Pharmaceutical
Animals
Antibodies, Monoclonal

Source PubMed

References1,015

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112,717,013Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor.Protein Sci2003https://conductscience.org/library/papers/12717013PubMed
226,821,017Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods.Int J Mol Sci2016https://conductscience.org/library/papers/26821017PubMed
337,229,604Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activity.MAbs2023https://conductscience.org/library/papers/37229604PubMed
48,899,829Kinetics and mechanism of the cleavage of the peptide bond next to asparagine.Peptides1996https://conductscience.org/library/papers/8899829PubMed
520,223,286Formulation strategy and use of excipients in pulmonary drug delivery.Int J Pharm2010https://conductscience.org/library/papers/20223286PubMed
626,756,795Effect of Excipients on Liquid-Liquid Phase Separation and Aggregation in Dual Variable Domain Immunoglobulin Protein Solutions.Mol Pharm2016https://conductscience.org/library/papers/26756795PubMed
72,095,560Analytical approaches to the study of monoclonal antibody stability.Pharm Res1990https://conductscience.org/library/papers/2095560PubMed
828,522,393Protein aggregation: From background to inhibition strategies.Int J Biol Macromol2017https://conductscience.org/library/papers/28522393PubMed
916,400,901Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions.Ann Allergy Asthma Immunol2005https://conductscience.org/library/papers/16400901PubMed
1021,846,562Aggregation, stability, and formulation of human antibody therapeutics.Adv Protein Chem Struct Biol2011https://conductscience.org/library/papers/21846562PubMed
1132,991,241Subcutaneous vaccine administration - an outmoded practice.Hum Vaccin Immunother2021https://conductscience.org/library/papers/32991241PubMed
1218,567,545Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G.J Chromatogr B Analyt Technol Biomed Life Sci2008https://conductscience.org/library/papers/18567545PubMed
1335,441,516Mechanism of Osmolyte Stabilization-Destabilization of Proteins: Experimental Evidence.J Phys Chem B2022https://conductscience.org/library/papers/35441516PubMed
1422,734,583Deamidation accelerates amyloid formation and alters amylin fiber structure.J Am Chem Soc2012https://conductscience.org/library/papers/22734583PubMed
1529,288,093Notorious but not understood: How liquid-air interfacial stress triggers protein aggregation.Int J Pharm2018https://conductscience.org/library/papers/29288093PubMed
1624,142,697Cysteine racemization on IgG heavy and light chains.J Biol Chem2013https://conductscience.org/library/papers/24142697PubMed
1721,507,961Covalent structural changes in unfolded GroES that lead to amyloid fibril formation detected by NMR: insight into intrinsically disordered proteins.J Biol Chem2011https://conductscience.org/library/papers/21507961PubMed
1820,621,282Protein aggregation from inclusion bodies to amyloid and biomaterials.Adv Protein Chem Struct Biol2010https://conductscience.org/library/papers/20621282PubMed
1932,743,712Formulation and Administration of Biological Medicinal Products".Pharm Res2020https://conductscience.org/library/papers/32743712PubMed
2034,516,988Characterization of N-Terminal Glutamate Cyclization in Monoclonal Antibody and Bispecific Antibody Using Charge Heterogeneity Assays and Hydrophobic Interaction Chromatography.J Pharm Sci2022https://conductscience.org/library/papers/34516988PubMed

See all 1,015 references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
42,943,301Impact of Aggregation on the Immunogenicity of Therapeutic Recombinant Biological Products.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943301PubMed
42,942,837The Stability-Release Paradox in Long-Acting Peptide and Protein Delivery: A Review of Material-Cargo Compatibility and Therapeutic Integrity.Pharmaceutics2026https://conductscience.org/library/papers/42942837PubMed
42,797,299Pharmaceutical Strategies for Translating Klotho-Based Therapeutics: From Biologic Developability to Advanced Delivery Systems.Pharmaceutics2026https://conductscience.org/library/papers/42797299PubMed
42,796,205Engineering Nanotherapeutics Through Interfacial Mechanics: Mechanobiology and Precision Drug Delivery.Micromachines (Basel)2026https://conductscience.org/library/papers/42796205PubMed
42,732,526Development of Freeze-Dried Formulations for Biopharmaceutical Drug Products Using a Design of Experiments Approach: A Case Study on Antibody-Drug Conjugates.Methods Mol Biol2026https://conductscience.org/library/papers/42732526PubMed
42,382,974Preventing physical and chemical degradation of the LABL-Fc-MOGR5, a bifunctional peptide inhibitor, with formulation development approaches.Antib Ther2026https://conductscience.org/library/papers/42382974PubMed
42,273,046Purification, characterization, and anticoagulant mechanism of an anticoagulant protein from marine Bacillus velezensis B01.Front Microbiol2026https://conductscience.org/library/papers/42273046PubMed
41,901,238Formulation Matters: The Overlooked Engine of Stability and Success in Antibody-Drug Conjugates.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41901238PubMed
41,754,810Stability Under Different Stress Treatments of a Virus-like Particle Vaccine Based on a Recombinant Hepatitis E Vaccine.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41754810PubMed
41,638,431Cosolute effects reveal the nature of weak forces governing GLP-1 oligomer stability.J Biol Chem2026https://conductscience.org/library/papers/41638431PubMed
41,007,619Advances in Techniques for the Structure and Functional Optimization of Therapeutic Monoclonal Antibodies.Biomedicines2025https://conductscience.org/library/papers/41007619PubMed
40,989,105Opportunities in formulation development of antibody-based therapeutics.Antib Ther2025https://conductscience.org/library/papers/40989105PubMed
40,969,138Specimen Inactivation Methods for Proteomics─Comparisons of Irradiation, Chemical, and Heat Treatments on Downstream Serum Analyses.J Proteome Res2025https://conductscience.org/library/papers/40969138PubMed
40,935,928Insights from a Survey of Drug Formulation Experts: Challenges and Preferences in High-Concentration Subcutaneous Biologic Drug Development.AAPS J2025https://conductscience.org/library/papers/40935928PubMed
40,931,003Stability Testing Reveals Photoselective Clipping of Heavy Chain C-Terminal Amino Acids That Leads to Fragmentation and Aggregation of an Antibody Fab Fragment.Mol Pharm2025https://conductscience.org/library/papers/40931003PubMed
40,593,991Preparation and property evaluation of oral colon targeted protein delivery system with sodium alginate and chitosan.Sci Rep2025https://conductscience.org/library/papers/40593991PubMed
40,578,813Physicochemical Comparison of Kolliphor HS 15, ELP, and Conventional Surfactants for Antibody Stabilization in Biopharmaceutical Formulations.Mol Pharm2025https://conductscience.org/library/papers/40578813PubMed
39,895,742Comprehensive Physicochemical Characterization and in Vitro Human Cell Culture Studies of an Innovative Biocompatible and Biodegradable Silk-Derived Protein Hydrolysate, SDP-4.ACS Omega2025https://conductscience.org/library/papers/39895742PubMed
39,635,133Conjugated therapeutic proteins as a treatment for bacteria which trigger cancer development.iScience2024https://conductscience.org/library/papers/39635133PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38937372

GET https://conductscience.org/api/papers/v1/38937372/references?page=2